Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Erinn B Broshko Insider Profile
4 Followers
Erinn B Broshko, Chairman at Med Biogene, holds 2.04M shares in Med Biogene (Ticker: TSE:MBI.H). Most recently, Erinn B Broshko Sold C$572,500 shares of Med Biogene on Mar 14, 2013 for an estimated value of 56.52K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+13.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Erinn B Broshko's holdings
Insider Roles
Chairman
Roles that Erinn B Broshko holds in companies
Most Profitable Insider Trade
The most profitable trade made by Erinn B Broshko
Erinn B Broshko's Trading History
List of latest transactions for each holding click on a transaction to see Erinn B Broshko's performance on stock
You May Also Like
Erinn B Broshko insider profile FAQ
What is the percentage of profitable transactions made by Erinn B Broshko?
The percentage of profitable transactions made by Erinn B Broshko is 33%.
What is the average return per transaction made by Erinn B Broshko?
The average return per transaction made by Erinn B Broshko is 13.10%.
What stocks does Erinn B Broshko hold?
Erinn B Broshko holds: TSE:MBI.H stocks.
What was Erinn B Broshko’s latest transaction?
Erinn B Broshko latest transaction was an Informative Sell of C$56.52K.
What was Erinn B Broshko's most profitable transaction?
Erinn B Broshko’s most profitable transaction was an Informative Buy of TSE:MBI.H stock on April 1, 2009. The return on the trade was 133.30%.
What is Erinn B Broshko's role in Med Biogene?
Erinn B Broshko's role in Med Biogene is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.